Digital Tactics
The Promise of Generative AI in Mitigating Bias in Continuing Medical Education
Continuing medical education (CME) is a top priority for healthcare providers in order to ...
10 Ways AI/ML Technologies Can Enhance Software Quality in the Life Sciences Industry
Quality in software is a multifaceted concept, closely tied to both conformance to requirements ...
Navigating a Greener Path: Sustainable Digital Advertising in Pharma
Pharma brands are increasingly humanizing the patient journey today unlike ever before. The growing ...
Striking a Balance: The Secret to Scaling-up Your Digital Products and Strategies Effectively
When launching a new digital product in pharma, one of the biggest challenges is ...
A Shift in Medical Affairs Amid the Challenge of Data Management and Rise of AI
The pharmaceutical industry is rapidly evolving its approach to strategic planning and decision-making. At ...
3 Ways AI is Already Changing Advertising (and None Are Generative AI)
Everyone’s buzzing about generative artificial intelligence (AI), and it’s true that technology like ChatGPT ...
6 Areas in the Life Sciences AI Will Surely Disrupt
The most talked about technology of the current moment for those in the life ...
Streaming Engagement: The Unique Opportunities in Connected TV
Last year was historic for the television industry. Why, you ask? In 2022, every ...
Media Retrenchment Is Opening a Window for Pharma to Rethink Ad Spend
For the next 12 to 24 months, the media landscape is set to drastically ...
What Tech Trends Do Life Sciences Marketers Need to Know About?
To discover how technology is affecting the jobs of life sciences marketers we turned ...
PM360 Q&A with Bill Veltre, Director, Omnichannel Strategy, Bristol Myers Squibb
With over 15 years of experience in health and wellness marketing and media, Bill ...
What Does the Metaverse Mean to Pharma?
Is the metaverse a worthwhile investment for pharma? Is the metaverse even a worthwhile ...
With Twitter’s Rebrand, Is it Time to Retire Brand Names with “X”?
Xanax, Xyzal, Xarelto, Xeljanz. The pharmaceutical field has an almost Elon Musk-ian attraction to ...
